Conference Sessions

Welcome to Seal Beach, California!

ACPN West Coast Regional Conference

Symptom Validity Assessment:
Implications for Practice, Ethics & Supervision
11 APA CE Hours (See the ACPN CE Policy on this site)


Sept 13-14, 2014

(Co-Sponsored by Green's Publishing)




Saturday, Sept 13, 2014  8:30—Noon

Session A:  How we use the WMT, MSVT and NV-MSVT to assess validity of cognitive test results.

Presenter: Paul Green, Ph.D.                 Green’s Publishing

Objectives:  Participants will…

  • Become familiar with multiple validity assessment tools.
  • Learn about basic and advanced use of these tools.
  • Be familiar with ethical implications of validity assessment.
  • Be able to discuss implications of the latest SVT research for neuropsychology supervisors.
  • Understand related financial and professional pressures.

Old Ranch Buffet Luncheon Served:   Noon—1:00 pm


Saturday, Sept 13, 2014  1:00pm—2:00pm

Presenter: Jeffrey Webster, PhD                            Long Beach, VAMC

This workshop will address the important topic of how failed SVT relates to treatment history, and prospective planning, as well as prognosis for outcome.  Predicting treatment benefit is of major importance to providers and healthcare organizations.  Rather than the methods of assessment, I will emphasize the practical importance of competent assessment of validity.  At the Long Beach VA, we serve veterans across the age group, and in many medial specialty clinics.  Demand for assistance with patients who ’fail to thrive’ in response to treatment efforts, as well as needs for assistance in practical planning, has become a major role for neuropsychology.  If not us, who else?  The literature on outcome as a function of SVT performance is scant.  I will present the results of recent research at the LBCAMC and discuss its implications.

Objectives:  Participants will…

  • Be familiar with current literature on SVT and outcome.
  • Be able to discuss treatment implications.
  • Learn about how to do cost effective treatment planning.
  • Learn implications and tools for feedback to referring staff.
  • Discuss  ethical and supervision implications


Saturday, Sept 13, 2014  2:00pm—3:30pm

Session A—Continued:  The cost of malingering to society and ethical dilemmas for professionals

Presenter: Paul Green, Ph.D.                      Green’s Publishing


Saturday, Sept 13, 2014  3:30pm—5:30pm

Session C  MMPI-2 and MMPI-2-RF

Presenter: Roger Gervais, PhD          Pvt Practice, Alberta, CA

Dr. Gervais will introduce the development and theory behind the RBS scale, as well as the skilled use of multiple MMPI scales for assessing validity.  He will discuss implications for diagnosis, treatment planning and management of the assessment process.  He will emphasize his research and practice since the release of the MMPI-2-RF.

Objectives:  Participants will…

  • Be familiar MMPI-2-RF validity tools.
  • Be able to discuss state of the art use of these scales.
  • Discuss implications for diagnosis.
  • List indicators for compliant versus ‘problem’ examinees.
  • Discuss  ethical and supervision implications


Day 2 Sessions

Sunday, September 14, 2014  8:30am—09:45am


Session A-Continued:  Non-Credible explanations of non-credible validity test failure

Presenter: Paul Green, Ph.D.                      Green’s Publishing


Panel Discussion 9:45 – Noon

Paul Green, PhD

Jeffrey Webster, Ph.D.

Roger Gervais, PhD

The faculty will discuss practical, ethical and supervision topics, introduce case studies and engage the participants in discussion of advanced methods, future research planning and continued emphasis on ethics in practice and supervision. 

Objectives:  Participants will…

  • Be familiar with current literature on SVT and outcome.
  • Future directions recommended by the panel.
  • Implications for ethical practice and supervision.


* Notice:  The speaker schedule is subject to change to accommodate needs that may arise.



Sunday September 14, 2014 - Noon

Optional 'Stay & Network Brunch' at Old Ranch